Predicting cognitive decline in amyloid‐negative individuals with amnestic mild cognitive impairment

Abstract

Background: A considerable portion of patients with amnestic mild cognitive impairment (aMCI) have negative amyloid‐β (Aβ) biomarkers and are therefore unlikely to have Alzheimer’s disease (AD).

The paper